Danaher Corporation $DHR Position Reduced by Benjamin Edwards Inc.

Key Points

• Benjamin Edwards Inc. cut its Danaher stake by 39.2% in Q4, selling 7,696 shares and leaving 11,955 shares worth about $2.74 million; institutional investors now own roughly 79.05% of the company.
• Danaher reported Q1 EPS of $2.06 (above the $1.94 estimate) while revenue was $5.95B versus $6B expected (up 3.7% YoY), and it declared a quarterly dividend of $0.40 ($1.60 annualized, 0.9% yield).

Benjamin Edwards Inc. decreased its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 39.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,955 shares of the conglomerate's stock after selling 7,696 shares during the period. Benjamin Edwards Inc.'s holdings in Danaher were worth $2,737,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Sivia Capital Partners LLC increased its holdings in shares of Danaher by 6.3% in the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate's stock valued at $397,000 after buying an additional 119 shares in the last quarter. First Trust Advisors LP increased its holdings in shares of Danaher by 34.5% in the second quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate's stock valued at $10,947,000 after buying an additional 14,217 shares in the last quarter. Main Street Financial Solutions LLC increased its holdings in shares of Danaher by 40.2% in the second quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate's stock valued at $610,000 after buying an additional 886 shares in the last quarter. Ieq Capital LLC increased its holdings in shares of Danaher by 64.2% in the second quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate's stock valued at $14,957,000 after buying an additional 29,592 shares in the last quarter. Finally, HUB Investment Partners LLC increased its holdings in shares of Danaher by 30.7% in the second quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate's stock valued at $273,000 after buying an additional 325 shares in the last quarter. Institutional investors own 79.05% of the company's stock.

Danaher Stock Performance

NYSE:DHR opened at $174.69 on Wednesday. Danaher Corporation has a 12-month low of $172.34 and a 12-month high of $242.80. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $123.64 billion, a PE ratio of 33.79, a price-to-earnings-growth ratio of 2.33 and a beta of 0.81. The firm has a 50-day moving average price of $192.65 and a 200 day moving average price of $213.03.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. During the same quarter in the prior year, the business posted $1.88 earnings per share. The company's quarterly revenue was up 3.7% compared to the same quarter last year. Research analysts anticipate that Danaher Corporation will post 8.43 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher's dividend payout ratio is 30.95%.

Analyst Upgrades and Downgrades

Several research firms have weighed in on DHR. Rothschild & Co Redburn set a $205.00 price objective on shares of Danaher in a research report on Friday, April 17th. JPMorgan Chase & Co. dropped their price target on shares of Danaher from $275.00 to $245.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 22nd. Wells Fargo & Company decreased their price objective on shares of Danaher from $240.00 to $212.00 and set an "equal weight" rating for the company in a report on Wednesday, April 22nd. Deutsche Bank Aktiengesellschaft reissued a "buy" rating on shares of Danaher in a research report on Thursday, January 29th. Finally, Wall Street Zen lowered shares of Danaher from a "buy" rating to a "hold" rating in a research report on Saturday, April 25th. Eighteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, Danaher has a consensus rating of "Moderate Buy" and an average target price of $240.70.

Insider Transactions at Danaher

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the transaction, the executive vice president owned 5,099 shares of the company's stock, valued at $1,060,642.99. This represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 10.80% of the stock is owned by company insiders.

Danaher Profile

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.